Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SISTER - Subcutaneous: Non-Interventional Study for Tysabri Patient Preference - Experience From Real World

NCT05304520 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT05304520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05304520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SISTER - Subcutaneous: Non-Interventional Study for Tysabri Patient Preference - Experience From Real World
Lead sponsor
Biogen
Phase
Observational
Overall status
Completed
Start date
October 12, 2021
Completion date
April 30, 2024
Enrollment
318 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis (rrms)